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a b s t r a c t
Background: The normal serum concentration of alkaline phosphatase (ALP) in adults over the age of 18 ranges
from 37 to 116 U/L, while in pregnant women levels of up to twice that upper limit can still be normal. There
have been very few reports of extreme elevations in ALP, and here we present the case of a 29-year-old pregnant
woman with an incidentally found 30-fold increase.
Case: The patient, G6P2–1–2-4, received routine prenatal care, though presented to obstetric triage at 36 weeks
and 1 day of gestation for diagnosis and management of viral rhinosinusitis and was found to have an ALP level of
2817 U/L. She was expectantly managed and levels were monitored during the peripartum period.
Conclusion: The literature proposes that elevation of the placental isotype of ALP could be a marker for placental
insufﬁciency, preterm delivery, or infants born large for gestational age. We report a case with delivery of a normal infant and no placental pathology at term.
© 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).

1. Introduction
Although obstetricians have observed elevations in serum alkaline
phosphatase (ALP) during pregnancy, these typically are not much
more than twice the pre-pregnancy upper limit of normal [1]. There is
currently a paucity of cases in which exaggerated increases are observed. Seeing an atypically elevated value can be distressing to both
the clinician and the patient, especially when it is unknown what the
implications may be. Some retrospective and prospective cohort studies
have shown that ALP could be a marker for preterm delivery, fetuses
that are large for gestational age, or conversely placental insufﬁciency
and intrauterine growth restriction [2,3,4]. This case serves to add to
the literature as a demonstration that even abnormal elevations of ALP
do not reliably predict fetomaternal pathology. This case is important
because it highlights the association between a very abnormal
biochemical value and good fetomaternal outcomes after expectant
management.
2. Case
A 29-year-old woman, gravida 6 para 2–1–2-4, received routine prenatal care at an academic practice at a university medical center. Her obstetric history was signiﬁcant for a preterm cesarean section of a
monochorionic, diamniotic twin pregnancy at 33 weeks as well as a successful vaginal birth after cesarean. Her routine laboratory tests were
unremarkable, including a normal glucose tolerance test at 26 weeks.
An anatomy ultrasound at 21 weeks of gestation was within normal
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limits. Her placental location was posterior with no correlation to her
previous cesarean scar. She presented to the obstetric triage unit at
36 weeks and 1 day of gestation with complaints of shortness of breath
and nasal congestion. Her workup was signiﬁcant for positive human
rhinovirus/enterovirus nasopharyngeal cultures. A comprehensive metabolic panel (CMP), which tests for serum electrolytes as well as hepatic
and renal function, was obtained as a part of her initial workup and incidentally showed an elevated ALP level of 2817 U/L. She was sent home
with recommendations for supportive care and was scheduled to
follow-up for routine prenatal care the following day in clinic. At her ofﬁce visit, a repeat CMP showed a continued ALP elevation, at 3143 U/L.
Fundal heights were consistently appropriate for gestational age. At her
next prenatal check the following week, the patient was still having persistent upper respiratory symptoms, for which a short course of
azithromycin was prescribed and another CMP with ALP isoenzyme differentiation was obtained. This showed a markedly elevated placental
isoenzyme, with low levels of both the liver and bone isoenzymes.
Knowing this breakdown, along with the absence of right upper quadrant pain, jaundice, or other signs of hepatic dysfunction, allowed an investigation for any liver pathology to be safely forgone. In the absence of
other indications for delivery, the shared decision was to plan for
another trial of labor after cesarean section at 39 weeks. Her labor was
induced with a Foley balloon and Pitocin. She had a successful vaginal
delivery of a viable, male, 3160-g infant. She received routine postpartum care. ALP levels were checked immediately postpartum
(2767 U/L), at two weeks postpartum (702 U/L), and at her six-week
postpartum visit (191 U/L). Thus the placental isoenzyme of ALP was elevated up until the second week after delivery. Laboratory tests six
weeks postpartum were unable to detect any placental isoenzyme.

https://doi.org/10.1016/j.crwh.2020.e00214
2214-9112/© 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

2

Z. Stanley et al. / Case Reports in Women's Health 27 (2020) e00214

3. Discussion

Contributors

Serum ALP has several different sources, but is found in all tissues of
the body. Each isotype has a unique molecular ﬁngerprint based on its origin. The main isotypes are found in the liver, bone, and placenta and they
are key enzymes in many metabolic pathways. If we had not known that
the increase was due to the placental isotype, there are other diagnoses
that would rise to the top of the list. We classically see moderate increases
in ALP associated with liver disease, which has a myriad of potential etiologies. When ALP is disproportionately elevated in comparison to hepatic transaminases and bilirubin, it is typically caused by an
obstructive disease process such as with cholelithiasis. As alluded to
above, previous case reports and small prospective and retrospective
studies have attempted to understand the signiﬁcance of abnormal elevations in serum ALP during pregnancy. In 1995, a retrospective review of
blood samples of women who underwent preterm delivery had elevated
ALP placental isoenzyme levels when compared to blood samples of
women who delivered at term [2]. In 2018, a prospective cohort study
found a correlation between early elevations of ALP (at 13–16 weeks of
gestation) and babies born large for gestational age, even in the setting
of normal glucose tolerance testing [3]. A case report from 2019 presents
a patient with elevated ALP levels and signs of placental insufﬁciency
with elevated umbilical artery dopplers and intrauterine growth restriction [4]. Our patient did not have any placental abnormalities, such as lacunae, and as its location was posterior, concern was low for abnormal
placentation. This is a case of an extremely elevated placental isoenzyme
of ALP in which the patient had low-risk outcomes for both the mother
and the baby. This serves as a reminder that we cannot reliably use an isolated, marked increase in serum ALP to dictate management in the setting
of an otherwise normal pregnancy.

All authors contributed equally to the chart review and construction
of this case report and meet criteria for authorship.

Teaching Point
• Extreme elevations in alkaline phosphatase during pregnancy may be expectantly managed in the absence of other fetomaternal considerations.
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